DK0867192T3 - Kombinationspræparat til anvendelse ved demens - Google Patents

Kombinationspræparat til anvendelse ved demens

Info

Publication number
DK0867192T3
DK0867192T3 DK98102620T DK98102620T DK0867192T3 DK 0867192 T3 DK0867192 T3 DK 0867192T3 DK 98102620 T DK98102620 T DK 98102620T DK 98102620 T DK98102620 T DK 98102620T DK 0867192 T3 DK0867192 T3 DK 0867192T3
Authority
DK
Denmark
Prior art keywords
dementia
combination preparation
preparation
combination
Prior art date
Application number
DK98102620T
Other languages
English (en)
Inventor
Karl Rudolphi
Hildegard Nimmesgern
Hans-Peter Schubert
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0867192T3 publication Critical patent/DK0867192T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK98102620T 1997-02-26 1998-02-16 Kombinationspræparat til anvendelse ved demens DK0867192T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19707655A DE19707655A1 (de) 1997-02-26 1997-02-26 Kombinationspräparat zur Anwendung bei Demenz
EP98102620A EP0867192B1 (de) 1997-02-26 1998-02-16 Kombinationspräparat zur Anwendung bei Demenz, enthaltend mindestens eine Verbindung die eine Acetylcholinesterase-Hemmwirkung oder muskarinerge Wirkung zeigt und eine Verbindung die den endogenen extrazellulären Adenosinspiegel erhöht

Publications (1)

Publication Number Publication Date
DK0867192T3 true DK0867192T3 (da) 2005-09-05

Family

ID=7821517

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98102620T DK0867192T3 (da) 1997-02-26 1998-02-16 Kombinationspræparat til anvendelse ved demens

Country Status (30)

Country Link
US (1) US6037347A (da)
EP (1) EP0867192B1 (da)
JP (1) JP4374440B2 (da)
KR (1) KR100517186B1 (da)
CN (1) CN100363005C (da)
AR (1) AR011860A1 (da)
AT (1) ATE295738T1 (da)
AU (1) AU749278C (da)
BR (1) BR9800766A (da)
CA (1) CA2230350C (da)
CZ (1) CZ298367B6 (da)
DE (2) DE19707655A1 (da)
DK (1) DK0867192T3 (da)
EE (1) EE03387B1 (da)
ES (1) ES2242243T3 (da)
HR (1) HRP980097B1 (da)
HU (1) HUP9800396A3 (da)
ID (1) ID19941A (da)
IL (1) IL123453A (da)
MY (1) MY120530A (da)
NO (1) NO327200B1 (da)
NZ (1) NZ329839A (da)
PL (1) PL191576B1 (da)
PT (1) PT867192E (da)
RU (1) RU2194508C2 (da)
SI (1) SI0867192T1 (da)
SK (1) SK284925B6 (da)
TR (1) TR199800302A3 (da)
TW (1) TW590772B (da)
ZA (1) ZA981561B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141762A0 (en) * 1998-10-01 2002-03-10 Novartis Ag New oral formulations
US20040110776A1 (en) * 2002-02-22 2004-06-10 Iok-Hou Pang Use of propentofylline to control intraocular pressure
AR039385A1 (es) * 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
AU2003270446A1 (en) * 2002-09-25 2004-04-19 The Board Of Trustees Of The University Of Illinois Method and composition for treating alzheimer's disease and dementias of vascular origin
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
CA2604617C (en) * 2005-04-28 2014-06-17 Eisai R&D Management Co., Ltd. Composition containing anti-dementia drug
TW200804383A (en) * 2006-06-05 2008-01-16 Astrazeneca Ab New compounds
WO2017044693A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
RU2616247C1 (ru) * 2016-03-28 2017-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737433A (en) * 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
US3621096A (en) * 1969-04-03 1971-11-16 Univ North Carolina Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2856393C2 (de) * 1978-12-27 1983-04-28 Merz + Co GmbH & Co, 6000 Frankfurt Arzneimittel zur Behandlung von Morbus Parkinson
EP0179383B1 (en) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
IL81610A (en) * 1986-02-27 1990-12-23 Roussel Uclaf Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
MX13270A (es) * 1987-10-05 1993-06-01 Pfizer Procedimiento para la preparacion de derivados de 4-aminopiridina
RU2039058C1 (ru) * 1988-03-30 1995-07-09 Пфайзер Инк. Производные 4-аминопиридина
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel
JPH05506842A (ja) * 1989-09-15 1993-10-07 ジェンシア・ファーマシュウティカルズ・インコーポレイテッド 神経変性状態の処置方法
RU2024509C1 (ru) * 1991-05-07 1994-12-15 Всероссийский научный центр по безопасности биологически активных веществ Производные 9-аминоакридина или их соли с органическими или неорганическими кислотами, проявляющие психотропную, антиамнестическую и липидрегулирующую активность
DE4236331A1 (de) * 1992-10-28 1994-05-05 Boehringer Ingelheim Kg Synergistische Kombination
US5783584A (en) * 1995-12-11 1998-07-21 Mayo Foundation For Medical Education And Research THA analogs useful as cholinesterase inhibitors
GB9612710D0 (en) * 1996-06-18 1996-08-21 Pfizer Ltd Method of treatment

Also Published As

Publication number Publication date
SI0867192T1 (en) 2005-10-31
HUP9800396A3 (en) 2001-05-28
ZA981561B (en) 1998-08-26
JPH10236979A (ja) 1998-09-08
ID19941A (id) 1998-08-27
DE59812801D1 (de) 2005-06-23
CZ54098A3 (cs) 1998-09-16
CA2230350C (en) 2007-07-24
PT867192E (pt) 2005-08-31
MX9801515A (es) 1998-08-30
JP4374440B2 (ja) 2009-12-02
HUP9800396A1 (hu) 1999-07-28
BR9800766A (pt) 1999-12-07
AU749278C (en) 2003-07-31
SK284925B6 (sk) 2006-02-02
AU749278B2 (en) 2002-06-20
CZ298367B6 (cs) 2007-09-12
EP0867192A3 (de) 2000-12-06
HU9800396D0 (en) 1998-04-28
RU2194508C2 (ru) 2002-12-20
EE03387B1 (et) 2001-04-16
IL123453A (en) 2004-06-20
NZ329839A (en) 2000-05-26
HRP980097B1 (en) 2006-09-30
IL123453A0 (en) 1998-09-24
NO980786L (no) 1998-08-27
DE19707655A1 (de) 1998-08-27
ES2242243T3 (es) 2005-11-01
PL191576B1 (pl) 2006-06-30
NO980786D0 (no) 1998-02-25
US6037347A (en) 2000-03-14
CN100363005C (zh) 2008-01-23
AR011860A1 (es) 2000-09-13
SK24098A3 (en) 1998-09-09
CN1192904A (zh) 1998-09-16
AU5627398A (en) 1998-09-03
EP0867192B1 (de) 2005-05-18
KR19980071717A (ko) 1998-10-26
MY120530A (en) 2005-11-30
TR199800302A2 (xx) 1998-09-21
TR199800302A3 (tr) 1998-09-21
EE9800075A (et) 1998-10-15
ATE295738T1 (de) 2005-06-15
HRP980097A2 (en) 1998-12-31
PL325074A1 (en) 1998-08-31
KR100517186B1 (ko) 2005-12-05
CA2230350A1 (en) 1998-08-26
EP0867192A2 (de) 1998-09-30
TW590772B (en) 2004-06-11
NO327200B1 (no) 2009-05-11

Similar Documents

Publication Publication Date Title
NO970320L (no) System for bruk ved brönn-komplettering
DK0912406T3 (da) Forbedringer ved containere
NO975973L (no) Anordning ved utblÕsningssikring
DK1226906T4 (da) Skaft til barberapparat
DK1167392T3 (da) Materialer til anvendelse i papirfremstilling
NO965581D0 (no) Anordning til bruk ved detonasjon
DE69806167D1 (de) Ausgiessvorrichtung
DE59707845D1 (de) Kryostatmikrotom
NO980786L (no) Kombinasjonspreparat for anvendelse ved demens
DE69819245D1 (de) Brotröster
FI974044A0 (fi) Spis
NO980675L (no) Sikkerhetsgitter
KR980000661U (ko) 커피 분쇄기
DE69802860D1 (de) Gewürzmühle
DE69700366D1 (de) Stabmixer
ITRM970524A0 (it) Il toglisinghiozzo
FI3061U1 (fi) Jalusta
KR980000588U (ko) 다용도 식판
KR970060794U (ko) 다용도 팽이
KR980003209U (ko) 철근 받침대
BR7701948U (pt) Liquidificador
DK0868279T3 (da) Forbedringer ved beholdere
BR7600177U (pt) Disposições construtivas introduzidas em carimbo de uso geral
NO974217D0 (no) Anordning ved hjulsats
SE9600682D0 (sv) Spiroazabicyclic compounds useful in therayp